|
End-of-day quote
Taiwan S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 56.80 TWD | -0.53% |
|
0.00% | +6.08% |
| Market Cap | 1.01TCr 31Cr 28Cr 26Cr 23Cr 44Cr 2.98TCr 44Cr 310.21Cr 123.56Cr 1.56TCr 117.38Cr 114.9Cr 4.95TCr | P/E 2024 |
12.6x | P/E 2025 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 871.37Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.56TCr 38Cr 266.32Cr 106.08Cr 1.34TCr 100.77Cr 99Cr 4.25TCr | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.29x |
| Free-Float |
44.21% | Yield 2024 |
4.52% | Yield 2025 | 3.4% |
| 1 day | -0.53% | ||
| Current month | +0.89% | ||
| 1 month | +1.07% | ||
| 3 months | -0.87% | ||
| 6 months | +2.26% | ||
| Current year | +6.08% |
| 1 week | 56.7 |  | 57.4 |
| 1 month | 55.6 | | 58.3 |
| Current year | 53.55 | | 60.55 |
| 1 year | 50.18 | | 60.55 |
| 3 years | 46.55 | | 72.18 |
| 5 years | 34.86 | | 72.36 |
| 10 years | 24.86 | | 72.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tzu-Ting Fan
CEO | Chief Executive Officer | - | 30/05/2006 |
Shu Hua Chen
IRC | Investor Relations Contact | - | - |
Wei Jen Chen
PRN | Corporate Officer/Principal | - | 01/04/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Chin Tsai Fan
CHM | Chairman | - | 30/06/1967 |
Tzu-Ting Fan
CHM | Chairman | - | - |
Yuan Te Li
BRD | Director/Board Member | - | 06/06/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | 0.00% | +12.37% | +2.59% | 31Cr | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,14300Cr | |
| +0.86% | +5.14% | +45.00% | +86.15% | 65TCr | |
| -0.14% | +0.42% | +25.69% | +105.85% | 51TCr | |
| -0.05% | +1.73% | +52.74% | +67.74% | 38TCr | |
| -0.63% | -5.97% | +61.93% | +37.06% | 35TCr | |
| +0.34% | +1.84% | +30.70% | +54.27% | 29TCr | |
| -0.45% | +1.19% | +2.89% | +26.08% | 26TCr | |
| +0.87% | +3.08% | +54.69% | +72.74% | 24TCr | |
| +0.08% | +3.67% | +35.05% | +107.78% | 20TCr | |
| Average | +0.08% | +1.29% | +37.81% | +69.02% | 40.28TCr | |
| Weighted average by Cap. | +0.25% | +1.55% | +44.50% | +89.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 678.92Cr 21Cr 19Cr 17Cr 16Cr 29Cr 1.99TCr 30Cr 207.5Cr 83Cr 1.04TCr 79Cr 77Cr 3.31TCr | 702.3Cr 22Cr 19Cr 18Cr 16Cr 30Cr 2.06TCr 31Cr 214.65Cr 85Cr 1.08TCr 81Cr 80Cr 3.42TCr |
| Net income | 88Cr 2.71Cr 2.43Cr 2.25Cr 2.04Cr 3.81Cr 258.43Cr 3.85Cr 27Cr 11Cr 135.23Cr 10Cr 9.97Cr 429.3Cr | 93Cr 2.86Cr 2.56Cr 2.37Cr 2.15Cr 4.01Cr 272.27Cr 4.06Cr 28Cr 11Cr 142.47Cr 11Cr 11Cr 452.3Cr |
| Net Debt | -124.36Cr -3.83Cr -3.44Cr -3.18Cr -2.88Cr -5.38Cr -364.98Cr -5.44Cr -38Cr -15Cr -190.99Cr -14Cr -14Cr -606.32Cr | -143.62Cr -4.43Cr -3.97Cr -3.67Cr -3.33Cr -6.21Cr -421.53Cr -6.29Cr -44Cr -17Cr -220.58Cr -17Cr -16Cr -700.26Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | NT$56.80 | -0.53% | 1,32,612 |
| 27/26/27 | NT$57.10 | +0.18% | 3,06,425 |
| 22/26/22 | NT$57.00 | +0.35% | 1,39,903 |
| 21/26/21 | NT$56.80 | -0.18% | 2,28,324 |
| 20/26/20 | NT$56.90 | -0.35% | 2,94,813 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1720 Stock
Select your edition
All financial news and data tailored to specific country editions
